KEAP1 and cancer: Through our studies, a subset of cancer‐associated KEAP1 mutations was found to disrupt the substrate‐recruiting function of Kelch domain to impair the ability of KEAP1 to bind and promote SOX9 poly‐ubiquitination and degradation.